2022 annual financial data
Akebia Therapeutics 2022 Net margin
Direct answer
Net margin was -32.22%.
Operating income was -80,779,000 USD and net income was -94,226,000 USD.
Operating cash flow was -73,154,000 USD.
Get free Akebia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 292,484,000 USD
- Operating income
- -80,779,000 USD
- Net income
- -94,226,000 USD
- Operating cash flow
- -73,154,000 USD